Skip to menu Skip to content Skip to footer

2010

Journal Article

The economic implications of treating atherothrombotic disease in australia, from the government perspective

Ademi, Zanfina, Liew, Danny, Hollingsworth, Bruce, Wolfe, Rory, Steg, Gabriel P., Bhatt, Deepak L. and Reid, Christopher M. (2010). The economic implications of treating atherothrombotic disease in australia, from the government perspective. Clinical Therapeutics, 32 (1), 119-132. doi: 10.1016/j.clinthera.2010.01.009

The economic implications of treating atherothrombotic disease in australia, from the government perspective

2009

Journal Article

Drug treatment and cost of cardiovascular disease in Australia

Ademi, Zanfina, Liew, Danny, Chew, Derek, Conner, Greg, Shiel, Louise, Nelson, Mark, Soman, Ash, Steg, Gabriel, Bhatt, Deepak L. and Reid, Christopher (2009). Drug treatment and cost of cardiovascular disease in Australia. Cardiovascular Therapeutics, 27 (3), 164-172. doi: 10.1111/j.1755-5922.2009.00090.x

Drug treatment and cost of cardiovascular disease in Australia

2009

Journal Article

Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia

Al-badriyeh, Daoud, Liew, Danny, Stewart, Kay and Kong, David C.M. (2009). Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia. Journal of Antimicrobial Chemotherapy, 63 (1), 197-208. doi: 10.1093/jac/dkn459

Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia

2006

Journal Article

A Model for Undertaking Effectiveness and Cost-Effectiveness Analyses of Primary Preventive Strategies in Cardiovascular Disease.

Liew, Danny A., Lim, Stephen S., Bertram, Melanie, McNeil, John J. and Vos, Theo (2006). A Model for Undertaking Effectiveness and Cost-Effectiveness Analyses of Primary Preventive Strategies in Cardiovascular Disease.. European Journal of Cardiovascular Prevention and Rehabilitation, 13 (4), 515-522. doi: 10.1097/01.hjr.0000224488.03221.97

A Model for Undertaking Effectiveness and Cost-Effectiveness Analyses of Primary Preventive Strategies in Cardiovascular Disease.

2005

Journal Article

Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged >= 70

Nelson, Mark R., Liew, Danny, Bertram, Melanie and Vos, Theo (2005). Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged >= 70. British Medical Journal, 330 (7503), 1306-1308A. doi: 10.1136/bmj.38456.676806.8F

Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged >= 70

2004

Conference Publication

Cost-effectiveness modelling of low-dose aspirin for the primary prevention of cardiovascular disease

Liew, D., Vos, T., Bertram, M., Lim, S. and McNeil, J. J. (2004). Cost-effectiveness modelling of low-dose aspirin for the primary prevention of cardiovascular disease. 44th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, San Francisco, CA United States, 3-6 March 2004. Philadelphia, PA United States: Lippincott Williams & Wilkins.

Cost-effectiveness modelling of low-dose aspirin for the primary prevention of cardiovascular disease

2004

Book Chapter

Benzodiazepines

Martin, J., Liew, D. and Johnson, S. (2004). Benzodiazepines. Alcohol and Drug Problems - A Case Studies Workbook. (pp. 132-157) edited by Gary Hulse. Oxford, United Kingdom: Oxford University Press.

Benzodiazepines

2004

Conference Publication

Comparative cost-effectiveness analyses of thiazide diuretics, betablockers, calcium channel blockers and antagonists of the renin angiotensin system for the primary prevention of cardiovascular disease

Liew, D., Bertram, M., Lim, S., McNeil, J. J. and Vos, T. (2004). Comparative cost-effectiveness analyses of thiazide diuretics, betablockers, calcium channel blockers and antagonists of the renin angiotensin system for the primary prevention of cardiovascular disease. 20th ISH Meeting, Sao Paulo, Brazil, 15-19 Feb 2004. Philadelphia, PA United States: Lippincott Williams & Wilkins.

Comparative cost-effectiveness analyses of thiazide diuretics, betablockers, calcium channel blockers and antagonists of the renin angiotensin system for the primary prevention of cardiovascular disease

2003

Journal Article

Eplerenone (Pharmacia)

Liew, Danny, Martin, Jennifer and Krum, Henry (2003). Eplerenone (Pharmacia). Current Opinion in Investigational Drugs, 4 (3), 316-322.

Eplerenone (Pharmacia)

2003

Journal Article

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy - In reply

Liew, D., McNeil, J. J., Peeters, A., Lim, S. S. and Vos, T. (2003). Epidemiological modelling (including economic modelling) and its role in preventive drug therapy - In reply. Medical Journal of Australia, 178 (4), 188-189.

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy - In reply

2003

Book Chapter

Cannabis, hallucinogens and CNS stimulants

Johnson, S., Martin, J. and Liew, D. (2003). Cannabis, hallucinogens and CNS stimulants. Alcohol and drug problems: A case studies workbook. (pp. 61-97) edited by Gary Hulse. Oxford, United Kingdom: Oxford University Press.

Cannabis, hallucinogens and CNS stimulants

2002

Conference Publication

Comparative cost-effectiveness of interventions for the primary prevention of coronary heart disease

Lim, S. S., Vos, T. E., Begg, S., Liew, D., Peeters, A. and McNeil, J. J. (2002). Comparative cost-effectiveness of interventions for the primary prevention of coronary heart disease. American Heart Association Scientific Sessions, Chicago, IL United States, 17-20 November 2002. Philadelphia, PA United States: Lippincott Williams & Wilkins.

Comparative cost-effectiveness of interventions for the primary prevention of coronary heart disease

2002

Journal Article

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy

Liew, D., McNeil, J. J., Peeters, A., Lim, S. S. and Vos, T. (2002). Epidemiological modelling (including economic modelling) and its role in preventive drug therapy. Medical Journal of Australia, 177 (7), 364-367.

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy

2001

Journal Article

Cost-effectiveness of prescribing statins according to Pharmaceutical Benefits Scheme criteria

Lim, Stephen S., Vos, Theo, Peeters, Anna, Liew, Danny and McNeil, John J. (2001). Cost-effectiveness of prescribing statins according to Pharmaceutical Benefits Scheme criteria. Medical Journal of Australia, 175 (9), 459-464. doi: 10.5694/j.1326-5377.2001.tb143676.x

Cost-effectiveness of prescribing statins according to Pharmaceutical Benefits Scheme criteria

2001

Journal Article

A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk

McNeil, J. J., Peeters, A., Liew, D., Lim, S. and Vos, T. (2001). A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk. Journal of Cardiovascular Risk, 8 (1), 31-37. doi: 10.1097/00043798-200102000-00005

A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk